top of page

Genomic Instability

BIO 4310: Cancer Biology

The hallmarks of cancer are a set of organized traits that describe how cancer develops and its progression. One of the new emerging hallmarks of is Genomic Instability. For this assignment, we were assigned an article that described many of the hallmarks in great detail. Genomic instability is a characteristic of most cancer. This hallmarks explains how instability within genome results from mutations within DNA repair mechanisms and causes cancer development to thrive cancer development. When cancer cells acquire mutations, these mutations enable the cancer cells to grow faster and continue to divide in large numbers. When these acquired mutations began to accumulate, they increase the risk of malignant tumors to form, resulting in cancer. This hallmark is one of the most important hallmarks because it explains how genome instability results from mutations within the cells, which increase the risk for cancer to develop. To learn more, download the presentation. 

Carcinogenesis

BIO 4310: Cancer Biology

Entresto

Bio 1315: Introduction to Biotechnology

Throughout the course, we learned about the process of carcinogenesis which describes the steps in which cancer and tumors develop. There are several different factors that induce carcinogenesis, which are carcinogens. For this assignment, we were assigned and article in which we had to read and interpret to direct the ways in which the process of carcinogenesis is induced or affected. The assigned article explained how high frequencies of Nitric Oxide production within human adenomas lead to the development of tumors. Nitric oxide is a gas that the body naturally produces and is categorized by three different types, NOS1, NOS2 and NOS3. The form NOS2 is critical to caner development because of its ability to cause mutations within cells. The studies explained in the article showed that mutations occurred more frequently in adenomas when there were higher concentrations of Nitric oxide. There are several experimental test completed on human adenoma tissue that showed large concentrations of NOS2 within blood vessels which allowed there to be a substantial blood supply feeding the tumors allowing them to grow and become malignant, thus inducing carcinogenesis. To learn more about Nitric oxide and cancer development, dow

Throughout the course, we explored the many benefits and advantages of biotechnology. One of the main aspects of biotechnology are biotech companies that used biotechnology to create, innovate, and develop many different medicines and treatments for several diseases. One of the biotech companies I explored was Novartis. Novartis is a biotech company that strives for innovation to develop products that will save and change the lives of their patients. One of the produces they develops is a drug known entresto. Entresto is a drug that targets heart disease. Enterso is a combination of two active ingredients sacubiril and valsartan. Both ingredients work together by inhibiting neprisylin and blocking the angiotensin receptor blocker. To learn more about Entersto, click the link below 

Slide01
Slide02
Slide03
Slide04
Slide05
Slide06
Slide07
Slide08
Slide09
Slide10
Slide11
Slide12
Slide13
Slide14
Slide15
Slide16
Slide17
Slide18
Slide19
Slide20
Slide21
Slide22
Slide23
Slide24
Slide25
Slide26
Slide27
Slide28
Slide01
Slide02
Slide03
Slide04
Slide05
Slide06
Slide07
Slide08
Slide09
Slide10
Slide1
Slide2
Slide3
Slide4
Slide5
Slide6
Slide7
Slide8

ORAL COMMUNICATIONS

Biomechanics of Ice Skating

PED 3411: Kinesiology 

In the course PED 3411, I learned about study of mechanics of body movements. This course focused on the study of human movement, investigating the mechanical, neurological, biochemical, physiological, and behavior components of human movement. For this presentation, we were to choose a sport and relate it to several mechanic moments along with anatomical physiology within the human body. To learn more about this presentation, download the link below. 

Slide01
Slide02
Slide03
Slide04
Slide05
Slide06
Slide07
Slide08
Slide09
Slide10
Slide11
bottom of page